Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study
Ghobrial, Irene M, Dr, Weller, Edie, PhD, Vij, Ravi, MD, Munshi, Nikhil C, MD, Banwait, Ranjit, MS, Bagshaw, Meghan, BA, Schlossman, Robert, MD, Leduc, Renee, BS, Chuma, Stacey, RN, Kunsman, Janet, NP, Laubach, Jacob, MD, Jakubowiak, Andrzej J, MD, Maiso, Patricia, PhD, Roccaro, Aldo, MD, Armand, Philippe, MD, Dollard, Akari, BA, Warren, Diane, BS, Harris, Brianna, BS, Poon, Tiffany, BS, Sam, Amy, BA, Rodig, Scott, MD, Anderson, Kenneth C, Prof, Richardson, Paul G, MD
Published in The lancet oncology (01.03.2011)
Published in The lancet oncology (01.03.2011)
Get full text
Journal Article